1. 774PThe role of adjuvant therapy in resectable SBA: A different clinicians attitude with a relevant impact on outcome. (23rd October 2018) Authors: Orsi, G; Andrikou, K; Bergamo, F; Nappo, F; Manai, C; Passardi, A; Puzzoni, M; Vallarelli, S; Libertini, M; Riggi, M L; Pugliese, G; Zaniboni, A; Schirripa, M; Procaccio, L; Silvestris, N; Scartozzi, M; Casadei Gardini, A; Zagonel, V; Cascinu, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PD-015Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies. (2nd July 2019) Authors: Rossini, D; Sbrana, A; Bergamo, F; Manai, C; Santini, D; Ghidini, M; Antoniotti, C; Moretto, R; Marmorino, F; Urbano, F; Ronzoni, M; Noventa, S; Randon, G; Carlomagno, C; Latiano, T; Cordio, S; Granetto, C; Cremolini, C; Falcone, A; Antonuzzo, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗